Medical

Magazine articles on health care providers, pharmaceutical companies, and medical technology.

Old Articles: <Older 3851-3860 Newer>

The Motley Fool July 6, 2007 Brian Orelli	Breaking Up Is Easy to Do Drugmaker Abraxis splits in two. It will be a few years before investors know whether the breakup was beneficial to the new companies.
The Motley Fool July 6, 2007 Brian Orelli	Pain-Free Phase 2 Data Anesiva's pain medication is moving up the clinical trial ladder. The Adlea results are very promising, but investors should look at the state of the entire company before investing.
The Motley Fool July 6, 2007 Brian Lawler	Medicines Decides Not to Share The Medicines Company reacquires its own drug. Until now, privately held European specialty pharma Nycomed has marketed Angiomax in Europe. Investors, take note.
The Motley Fool July 6, 2007 Brian Lawler	Elan Goes to the Isles The drugmaker wins an important battle in the U.K., but shares are still priced for more than perfection.
The Motley Fool July 6, 2007 Brian Lawler	Another Round for Alkermes' Alcohol Fight Alkermes advances the development of another drug. Investors, take note.
The Motley Fool July 6, 2007 Billy Fisher	Medtronic: For the Broken-Hearted Promising clinical trial could bring a new Medtronic stent to market. Investors, take note.
CRM July 1, 2007 Marshall Lager	Market Focus: Healthcare: The Great Divide The healthcare industry continues to have issues defining itself and its approach to CRM - but that's because it's more than one industry: the business of medicine and the care of patients.
Chemistry World July 2007 Victoria Gill	Conflict of interest? The FDA has been questioned after a published study brought exposed cardiovascular risks associated with GlaxoSmithKline's diabetes drug, Avandia.
Chemistry World July 2007 Derek Lowe	Opinion: In the Pipeline The Avandia controversy poses some tough questions about how to balance risks and showcases much broader implications for the pharmaceutical industry beyond this one drug.
Managed Care June 2007	A Conversation with Jonathan Weiner, DrPH: Mixing Population-Based Care With Market Controls The United States' health care system needs consumer and market controls to succeed, but it can't rely on only those two factors.
<Older 3851-3860 Newer> Return to current articles.